Status:

TERMINATED

Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy

Lead Sponsor:

Indiana University

Conditions:

Kidney Stone

Surgery

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine if adding a spinal block (medicine that will numb parts of the body to block pain) along with standard pain control at the incision site will decrease the nee...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years Undergoing unilateral or bilateral PCNL for treatment of kidney stones Estimated glomerular filtration rate \> 30 mL/min. PCNL is planned as an outpatient procedure with no overnight hospital stay

Exclusion

  • Inability to provide informed consent Pregnancy Patients having any additional simultaneous procedures other than a contralateral PCNL,(including contralateral treatment of kidney stones with a non-PCNL operation such as ureteroscopy) Patients with a documented neurologic injury that reduces pain sensation to the back Patients with an existing pain disorder Patients with an existing narcotics agreement due to current or prior narcotic abuse Patients with a documented allergy to a narcotic or NSAID analgesic BMI \> 35 Patients who require more than 1 site of percutaneous access into the kidney to adequately complete the PCNL (this is a judgment made preoperatively at the initial clinic patient encounter)

Key Trial Info

Start Date :

February 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 24 2020

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT04663269

Start Date

February 24 2020

End Date

September 24 2020

Last Update

April 23 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Methodist University

Indianapolis, Indiana, United States, 46202